🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsDosing & ProtocolsSteady-state concentrations across dose tiers — need advice

Steady-state concentrations across dose tiers — need advice

cory_ATX Fri, Mar 20, 2026 at 2:05 AM 9 replies 798 viewsPage 1 of 2
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Mar 20, 2026 at 3:30 AM#1

Steady-state concentrations across dose tiers — need advice

Saw this come across my feed today and thought the community would want to discuss.

Steady-state concentrations across dose tiers need is something that affects a lot of us here, and the latest information is worth paying attention to. I'll share what I know and hopefully others can fill in the gaps.

Key points as I understand them:

  • This has been evolving over the past few months
  • There are different perspectives on how to approach it
  • The practical implications depend on your specific situation

What are you all hearing from your providers about this? Anyone have direct experience to share?

41 11Dr.EndoEP, GraceAZ_72, carl_compliance and 38 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Mar 20, 2026 at 3:47 AM#2

Steady-state concentrations across dose — I actually dealt with this exact situation around month 3.

Short answer: talk to your prescriber first. Longer answer: I wrote about my experience in the results forum if you want the full details.

22 11TinaHashiRN, robert_kc, dan_philly and 19 others
Reply Quote Save Share Report
Dr.PeteFamMed
Senior Member
2,012
9,234
Jan 2024
Minneapolis, MN
Mar 20, 2026 at 4:04 AM#3
PharmD_Rodriguez said:
Short answer: talk to your prescriber first

Completely agree with PharmD_Rodriguez. I would add that Steady-state concentrations also has implications for body composition that sometimes get overlooked in these discussions.

In my case, following a similar approach led to fewer side effects compared to what I was doing before.

16 2LindaRN_retired, tommy_boulder, hyun_seoul and 13 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Mar 20, 2026 at 4:21 AM#4

This thread is incredible for Steady-state info. Better than most online groups.

35 24james_edin, FranDenver, Dr.BariatricHTX and 32 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Mar 20, 2026 at 4:38 AM#5

As a healthcare provider, I want to add some clinical context to this discussion on Steady-state concentrations across dose.

Building on what cory_ATX said — the evidence base here is well-established. The key publications to reference are from the FLOW program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
10 8TomFromTexas, mike.trainer_LA, sarah_nash92 and 7 others
Reply Quote Save Share Report

Similar Threads

Micro-dosing semaglutide — is sub-therapeutic dosing effective?16 replies
Injection technique: subcutaneous depot formation and absorption8 replies
Semaglutide PK modeling — when to time your injection12 replies
Reconstitution calculator — compounded peptide dosing math7 replies
Half-life implications for missed doses — PK-based guidance5 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register